Novartis Pharma AG

Switzerland · Reporting entity ID 100000000058

Total reported 2019–2025

$14.4M

#400 of 2,960 reporting companies — 0% of all reported industry payments

$4.58M in general payments across 1,708 records, plus $9.81M in research funding across 1,353 records.

How it breaks down

General payments $4,581,816

Research funding $9,813,508

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.